These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24260260)

  • 1. Identification of highly methylated genes across various types of B-cell non-hodgkin lymphoma.
    Bethge N; Honne H; Hilden V; Trøen G; Eknæs M; Liestøl K; Holte H; Delabie J; Smeland EB; Lind GE
    PLoS One; 2013; 8(11):e79602. PubMed ID: 24260260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A gene panel, including LRP12, is frequently hypermethylated in major types of B-cell lymphoma.
    Bethge N; Honne H; Andresen K; Hilden V; Trøen G; Liestøl K; Holte H; Delabie J; Lind GE; Smeland EB
    PLoS One; 2014; 9(9):e104249. PubMed ID: 25226156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma.
    Eberth S; Schneider B; Rosenwald A; Hartmann EM; Romani J; Zaborski M; Siebert R; Drexler HG; Quentmeier H
    BMC Cancer; 2010 Sep; 10():517. PubMed ID: 20920234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
    Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
    Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer DNA methylation marker panel validated with high performance in Non-Hodgkin lymphoma.
    Bethge N; Lothe RA; Honne H; Andresen K; Trøen G; Eknæs M; Liestøl K; Holte H; Delabie J; Smeland EB; Lind GE
    Epigenetics; 2014 Mar; 9(3):428-36. PubMed ID: 24362313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy.
    Zhang MY; Calin GA; Yuen KS; Jin DY; Chim CS
    Clin Epigenetics; 2020 Oct; 12(1):150. PubMed ID: 33076962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomas.
    Wang Z; Li L; Su X; Gao Z; Srivastava G; Murray PG; Ambinder R; Tao Q
    J Transl Med; 2012 Oct; 10():209. PubMed ID: 23050586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas.
    Piccaluga PP; Califano A; Klein U; Agostinelli C; Bellosillo B; Gimeno E; Serrano S; Solè F; Zang Y; Falini B; Zinzani PL; Pileri SA
    Haematologica; 2008 Jul; 93(7):1033-8. PubMed ID: 18492688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State of the Art and Future Needs in Cytogenetic/Molecular Genetics/Arrays in childhood lymphoma: summary report of workshop at the First International Symposium on childhood and adolescent non-Hodgkin lymphoma, April 9, 2003, New York City, NY.
    Heerema NA; Bernheim A; Lim MS; Look AT; Pasqualucci L; Raetz E; Sanger WG; Cairo MS
    Pediatr Blood Cancer; 2005 Oct; 45(5):616-22. PubMed ID: 16127683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential DNA methylation of gene promoters in small B-cell lymphomas.
    Guo J; Burger M; Nimmrich I; Maier S; Becker E; Genc B; Duff D; Rahmatpanah F; Chitma-Matsiga R; Shi H; Berlin K; Huang TH; Caldwell CW
    Am J Clin Pathol; 2005 Sep; 124(3):430-9. PubMed ID: 16191512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific methylation of the 8p22 tumor suppressor gene DLC1 is an epigenetic biomarker for Hodgkin, nasal NK/T-cell and other types of lymphomas.
    Ying J; Li H; Murray P; Gao Z; Chen YW; Wang Y; Lee KY; Chan AT; Ambinder RF; Srivastava G; Tao Q
    Epigenetics; 2007; 2(1):15-21. PubMed ID: 17965626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of two unannotated miRNAs in classic Hodgkin lymphoma cell lines.
    Ustaszewski A; Paczkowska J; Janiszewska J; Bernhart SH; Bein J; Russiñol N; Hansmann ML; Chapaprieta V; Martín-Subero JI; Siebert R; Hartmann S; Giefing M
    PLoS One; 2023; 18(3):e0283186. PubMed ID: 36961799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas.
    Dogan A; Bagdi E; Munson P; Isaacson PG
    Am J Surg Pathol; 2000 Jun; 24(6):846-52. PubMed ID: 10843287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation profiling of transcription factor genes in normal lymphocyte development and lymphomas.
    Ivascu C; Wasserkort R; Lesche R; Dong J; Stein H; Thiel A; Eckhardt F
    Int J Biochem Cell Biol; 2007; 39(7-8):1523-38. PubMed ID: 17433759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between lymphoma prognosis and aberrant methylation of ID4 and ZO-1 in bone marrow and paraffin-embedded lymphoma tissues of treatment-naive patients.
    Cen J; Shen J; Wang X; Kang H; Wang L; Sun L; Li Y; Yu L
    Oncol Rep; 2013 Jul; 30(1):455-61. PubMed ID: 23670122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling.
    Martín-Subero JI; Kreuz M; Bibikova M; Bentink S; Ammerpohl O; Wickham-Garcia E; Rosolowski M; Richter J; Lopez-Serra L; Ballestar E; Berger H; Agirre X; Bernd HW; Calvanese V; Cogliatti SB; Drexler HG; Fan JB; Fraga MF; Hansmann ML; Hummel M; Klapper W; Korn B; Küppers R; Macleod RA; Möller P; Ott G; Pott C; Prosper F; Rosenwald A; Schwaenen C; Schübeler D; Seifert M; Stürzenhofecker B; Weber M; Wessendorf S; Loeffler M; Trümper L; Stein H; Spang R; Esteller M; Barker D; Hasenclever D; Siebert R;
    Blood; 2009 Mar; 113(11):2488-97. PubMed ID: 19075189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel.
    Cicek MS; Koestler DC; Fridley BL; Kalli KR; Armasu SM; Larson MC; Wang C; Winham SJ; Vierkant RA; Rider DN; Block MS; Klotzle B; Konecny G; Winterhoff BJ; Hamidi H; Shridhar V; Fan JB; Visscher DW; Olson JE; Hartmann LC; Bibikova M; Chien J; Cunningham JM; Goode EL
    Hum Mol Genet; 2013 Aug; 22(15):3038-47. PubMed ID: 23571109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
    Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
    J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B5b (CYB5B).
    Murphy D; Parker J; Zhou M; Fadlelmola FM; Steidl C; Karsan A; Gascoyne RD; Chen H; Banerjee D
    Mol Cancer; 2010 Jan; 9():14. PubMed ID: 20100355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia.
    Rossi D; Capello D; Gloghini A; Franceschetti S; Paulli M; Bhatia K; Saglio G; Vitolo U; Pileri SA; Esteller M; Carbone A; Gaidano G
    Haematologica; 2004 Feb; 89(2):154-64. PubMed ID: 15003890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.